NIH-funded research Fellowship grant

Understanding how cells interact at the uterine-placental interface during pregnancy

Official title: Signaling at the Uterine Placental Interface

Funded at University of Kansas Medical Center · NIH-10890618 · Data updated 2026-11-12

This study is looking at how cells from a mother and her baby work together in the uterus to ensure the baby grows healthy, focusing on how certain cells help with blood flow and nutrients; it's for anyone interested in understanding more about what can go wrong during pregnancy.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJuly 17, 2023
Project endJuly 16, 2027
Funding year2024
Award (this year)$37,752
NIH project number5F31HD113433-02
Project IDNIH-10890618 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals experiencing complications or those at risk for conditions like preeclampsia or intrauterine growth restriction.

Less likely to help

Patients who are not pregnant or those with unrelated health conditions may not benefit from this research.

What this research studies

This research investigates the interactions between maternal and fetal cells at the uterine-placental interface, which are crucial for healthy fetal development. It focuses on trophoblast stem cells and their ability to invade the uterus, a process that is essential for proper blood flow and nutrient delivery to the fetus. By using both rat models and human trophoblast stem cells, the study aims to uncover the molecular mechanisms that regulate this invasion and how failures in this process can lead to pregnancy complications. Advanced techniques like single-cell RNA sequencing are employed to identify key regulators involved in trophoblast cell differentiation.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for pregnancy-related complications such as preeclampsia and early pregnancy loss.

How similar studies have gone: Other research has shown promise in understanding trophoblast cell behavior, but this specific approach using CRISPR and single-cell sequencing is relatively novel.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Simon, Mikaela Elizabeth — University of Kansas Medical Center
  • Study coordinator: Simon, Mikaela Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.